When Low-Priced Stocks Are The Biggest Leaders (CYBI, MNI, BMTI, SPF)
Is it a worry when the percentage gainers are all low-priced stocks? For some it may be, others will just say it is the normal process. Cybex International, Inc. (NASDAQ: CYBI) is up 23% at $1.47 and only on 202,000…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Is it a worry when the percentage gainers are all low-priced stocks? For some it may be, others will just say it is the normal process.
Cybex International, Inc. (NASDAQ: CYBI) is up 23% at $1.47 and only on 202,000 shares of volume. This is on the heels the company reaching a settlement in the Barnhard product liability suit.
The McClatchy Company (NYSE: MNI) is up 24% at $2.78 and not quite on 2 million shares as of yet. This surge is after the company beat its earnings predictions and after tuting its digital efforts in the world of old media meets new media.
BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) is up 17% on 2.8 million shares at $2.40. Biomimetic’s news is that the company announced results of its 30 patient Canadian Augment Rotator Cuff Graft clinical trial and that the results achieved the primary safety endpoint.
Standard Pacific Corp. (NYSE: SPF) is up 18.5% to $4.80 on 6.7 million shares. The single-family homebuilder announced earnings ahead of estimates.
Contact [email protected] for any questions or corrections.
Jon Ogg has been a financial news analyst since 1997. Mr. Ogg set up one of the first audio squawk box services for traders called TTN, which he sold in 2003. He has previously worked as a licensed broker to some of the top U.S. and E.U. financial institutions, managed capital, and has raised private capital at the seed and venture stage. He has lived in Copenhagen, Denmark, as well as New York and Chicago, and he now lives in Houston, Texas. Jon received a Bachelor of Business Administration in finance at University of Houston in 1992. www.247wallst.com.
